Clin2
NCT05688579Possibly a fitEnrolling by invitation

Testing an aldosterone-blocking medicine in hard-to-control hypertension

HypertensionHyperaldosteronaemia

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial studies whether a medicine that blocks aldosterone (called an MRA) can improve cardiovascular outcomes in people with high aldosterone levels and high blood pressure. You may be asked to take the study medicine and have blood pressure, heart, and lab tests monitored over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
8,000 people
Ages
30 years to 75 years
Study type
Interventional

Who can take part

  • Be between 18 and 75 years old
  • Have blood pressure ≥140/90, or currently take blood pressure medicine
  • Have blood tests showing high aldosterone (more than 12 ng/dL)
  • Have potassium blood level under 4.8 mmol/L
  • Agree to sign informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05593055Recruiting· Phase 4
Test a heart and blood-pressure therapy in people with hypertension

This study looks at how mineralocorticoid-related hormone signaling affects small heart blood vessels and how efficiently the heart works in people with high blood pressure. It may help doctors understand which treatments could improve heart function in hypertension.

Boston, Massachusetts
NCT07137364Recruiting
Testing spironolactone with blood pressure drugs for PA

This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.

Chongqing, Chongqing Municipality
NCT06941116Recruiting
Steroid test to screen for a common cause of high blood pressure

This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.

Chongqing, Chongqing Municipality
NCT07748975Not yet recruiting
Study of a blood pressure hormone and a silencing treatment

This trial looks at how a natural hormone called aldosterone (which helps control blood pressure) and a treatment that silences it affect people with high blood pressure. It aims to find better ways to manage high blood pressure by studying real patient data.

Vadhana, Bangkok
NCT06513676Recruiting
Adrenal artery treatment for aldosteronism study

This study tests a procedure that blocks tiny arteries in the adrenal gland to treat high blood pressure and low potassium caused by aldosteronism. It may be an option if you cannot take medications or cannot have surgery.

Ürümqi, Xinjiang
NCT06108427Recruiting
Renin-guided treatment with aldosterone blockers in primary aldosteronism

This study tests whether adjusting a type of blood pressure medication (called a mineralocorticoid receptor antagonist) based on renin levels is safe and helpful for people with primary aldosteronism. It aims to find a better way to manage the condition.

Montreal, Quebec

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.